Teleradiology Market to Reach USD 14.67 Billion by 2031 Growing Demand for Remote Diagnostic Services and AI-Enabled Imaging Solutions Accelerates Market Expansion, Says Mordor Intelligence

Mordor Intelligence estimates the global teleradiology market at $7.60B in 2026, rising to $14.67B by 2031 (14.08% CAGR), driven by a radiologist shortage, higher imaging volumes, and rapid healthcare digitization. Growth is supported by adoption of cloud-based imaging/PACS-RIS workflows and AI-assisted image analysis for faster reporting and improved diagnostic prioritization. The update is constructive for the sector but is primarily industry/market-research reporting, with limited direct near-term price impact for specific public companies.

Analysis

This reads as a workflow-displacement story more than a pure demand boom. The equity upside should accrue to the software layer that sits between image acquisition and final read: PACS/RIS, cloud storage, interoperability, cybersecurity, and AI triage. By contrast, standalone reading networks are vulnerable to commoditization because AI lowers the cost of routine reads and gives hospital systems more leverage to internalize volume, which can lift reported study counts without lifting margins.

Second-order beneficiaries are the imaging equipment and hospital efficiency stack: if turnaround times improve, utilization can rise and bottlenecks in CT/MRI scheduling can loosen over 6-18 months. But that lag matters; procurement cycles and IT integration are slow, so near-term earnings impact is more likely to show up in backlog and implementation spend than in immediate revenue acceleration. The market may be overestimating how quickly this translates into sustainable pricing power.

The contrarian risk is that consensus treats the market-size CAGR as if it were equity alpha. In reality, faster AI-assisted triage could cap the labor shortage narrative that supports outsourced radiology pricing, while also shifting bargaining power back to large health systems. The thesis is most vulnerable if hospitals use cloud platforms to bring more reads in-house, if reimbursement does not expand with remote reporting, or if cybersecurity/regulatory friction slows deployment; that would make this a multi-quarter margin story, not a top-line rerate.

Key Decisions for Investors

• No immediate trade in MEDD or AFGVY on this report alone; treat as a watch item until next quarterly filing shows bookings, ARR, or margin inflection. Horizon: 1-2 quarters.
• Conditional long AFGVY only if healthcare IT revenue mix and order intake reaccelerate; use it as a smaller, higher-risk expression of PACS/workflow adoption. Falsify if Europe demand or implementation cadence weakens.
• Long GEHC or PHG on pullbacks as higher-quality proxies for imaging workflow digitization and AI-assisted radiology tooling. Horizon: 6-12 months; thesis breaks if software/orders decelerate or China softness deepens.
• If a liquid pure-play teleradiology operator becomes accessible, consider a short only on evidence of margin compression from AI-assisted insourcing; otherwise keep it on an alert list rather than forcing the trade.
• Relative-value idea: long a healthcare software basket such as IGV versus a broad healthcare services proxy like IYH if the next 1-3 months show continued cloud/PACS adoption but muted outsourcing economics. Risk/reward improves only if implementation data confirms vendors are monetizing the shift.